Kim D Jones1, Scott D Mist2, Marie A Casselberry3, Ather Ali4, Michael S Christopher5. 1. Oregon Health & Science University, Mail Code SN-ORD, 3455 SW US Veterans Hospital Road, Portland, OR 97239. Electronic address: joneskim@ohsu.edu. 2. Oregon Health & Science University, Portland, OR. 3. Zoom Care, Portland, OR. 4. Yale University, New Haven, CT. 5. Pacific University, Forest Grove, OR.
Abstract
CONTEXT AND OBJECTIVE: A growing body of literature suggests that mindfulness techniques may be beneficial in fibromyalgia. A recent systematic review and meta-analysis of six trials indicated improvement in depressive symptoms and quality of life, calling for increased rigor and use of standardized measures in future trials. The purpose of the study was to examine the relationship between mindfulness [as measured by the Five Facet Mindfulness Questionnaire (FFMQ)] and fibromyalgia impact [as measured by the Revised Fibromyalgia Impact Questionnaire (FIQR)]. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional survey was conducted with adults diagnosed with fibromyalgia from a national fibromyalgia advocacy foundation e-mail list. RESULTS: A total of 4986 respondents represented all 50 states in the United States and 30 countries. FIQR scores demonstrated moderate to severe fibromyalgia with the majority of subjects (59%) scoring ≤60. Scores on the FFMQ subscales ranged from 20.8 to 27.3, with highest scores for the observe subscale. All subscale correlations were small to moderate and indicated that more severe fibromyalgia impact was associated with less mindfulness except in the observe scale (r = .15, P > .000). No clinical or demographics explained as much variance in the FIQR total as any of the mindfulness subscales. CONCLUSIONS: Fibromyalgia patients experience symptoms that may be alleviated by mindfulness interventions. Baseline values for the observe subscale of the FFMQ were unexpectedly high. Further research is needed to know if this may be due to non-mindful observations and should be noted when the FFMQ is used in fibromyalgia clinical trials.
CONTEXT AND OBJECTIVE: A growing body of literature suggests that mindfulness techniques may be beneficial in fibromyalgia. A recent systematic review and meta-analysis of six trials indicated improvement in depressive symptoms and quality of life, calling for increased rigor and use of standardized measures in future trials. The purpose of the study was to examine the relationship between mindfulness [as measured by the Five Facet Mindfulness Questionnaire (FFMQ)] and fibromyalgia impact [as measured by the Revised Fibromyalgia Impact Questionnaire (FIQR)]. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional survey was conducted with adults diagnosed with fibromyalgia from a national fibromyalgia advocacy foundation e-mail list. RESULTS: A total of 4986 respondents represented all 50 states in the United States and 30 countries. FIQR scores demonstrated moderate to severe fibromyalgia with the majority of subjects (59%) scoring ≤60. Scores on the FFMQ subscales ranged from 20.8 to 27.3, with highest scores for the observe subscale. All subscale correlations were small to moderate and indicated that more severe fibromyalgia impact was associated with less mindfulness except in the observe scale (r = .15, P > .000). No clinical or demographics explained as much variance in the FIQR total as any of the mindfulness subscales. CONCLUSIONS:Fibromyalgiapatients experience symptoms that may be alleviated by mindfulness interventions. Baseline values for the observe subscale of the FFMQ were unexpectedly high. Further research is needed to know if this may be due to non-mindful observations and should be noted when the FFMQ is used in fibromyalgia clinical trials.
Authors: Ruth A Baer; Gregory T Smith; Emily Lykins; Daniel Button; Jennifer Krietemeyer; Shannon Sauer; Erin Walsh; Danielle Duggan; J Mark G Williams Journal: Assessment Date: 2008-02-29
Authors: Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe Journal: Arthritis Rheum Date: 2008-01
Authors: Robert M Bennett; Andrew G Bushmakin; Joseph C Cappelleri; Gergana Zlateva; Alesia B Sadosky Journal: J Rheumatol Date: 2009-04-15 Impact factor: 4.666
Authors: Brandon Pleman; Michelle Park; Xingyi Han; Lori Lyn Price; Raveendhara R Bannuru; William F Harvey; Jeffrey B Driban; Chenchen Wang Journal: Clin Rheumatol Date: 2019-01-14 Impact factor: 2.980
Authors: Albert Feliu-Soler; Xavier Borràs; María T Peñarrubia-María; Antoni Rozadilla-Sacanell; Francesco D'Amico; Rona Moss-Morris; Matthew A Howard; Nicolás Fayed; Carles Soriano-Mas; Marta Puebla-Guedea; Antoni Serrano-Blanco; Adrián Pérez-Aranda; Raffaele Tuccillo; Juan V Luciano Journal: BMC Complement Altern Med Date: 2016-02-27 Impact factor: 3.659
Authors: Albert Feliu-Soler; Ignacio Martínez-Zalacaín; Adrián Pérez-Aranda; Xavier Borràs; Laura Andrés-Rodríguez; Juan P Sanabria-Mazo; Nicolás Fayed; Christian Stephan-Otto; Christian Núñez; Carles Soriano-Mas; Juan V Luciano Journal: J Clin Med Date: 2020-01-30 Impact factor: 4.241
Authors: Alberto Amutio; Clemente Franco; Laura C Sánchez-Sánchez; María Del C Pérez-Fuentes; José J Gázquez-Linares; William Van Gordon; María Del M Molero-Jurado Journal: Front Psychol Date: 2018-08-03